DexTech Medical AB, Year-end report July 1, 2021 - June 30, 2022
Summary of the fourth quarter (2022-04-01 – 2022-06-30) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,3 (-2,1) · Earnings per share* SEK -0.06 (-0.11) * Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 18,485,857. For the comparison period, the average number of shares was 18,485,857. Amounts in brackets refer to the corresponding period last year. Summary of the financial year (2021-07-01 – 2022-06-30) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss